Trial Profile
Phase I trial of tivantinib and sorafenib in patients with liver cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Oct 2012
Price :
$35
*
At a glance
- Drugs Tivantinib (Primary) ; Sorafenib
- Indications Liver cancer
- Focus Therapeutic Use
- 06 Oct 2009 Status changed from planning to recruiting, according to an ArQule media release.
- 08 Apr 2009 New trial record.